Who Should Not Get LDRT? Contraindications and Cautions

Our candidacy page lists the situations that need a closer look: pregnancy, past radiation to the same area, connective tissue disease, and pain that may come from somewhere else. This page goes further. For each topic it covers why the team cares, whether it ends the conversation or just changes the timing, what usually happens instead, and the question to ask at your consultation.

Most of these items do not end the conversation. They pause it. One item does end it for now, and that is pregnancy, because the treatment is elective and the pain has other treatments that can carry you through. Everything else comes down to facts the team can check: what dose the joint has already had, how old you are, what other conditions affect the tissue, and whether the pain really is osteoarthritis.

Pregnancy: The One Hard Stop

A 2025 review of low-dose radiotherapy for benign diseases states: radiotherapy is absolutely contraindicated during pregnancy, and women of reproductive age are advised to use other treatment options first^[1]. The research trials draw the same line. The German ArthroRad trial of low-dose radiotherapy for hand and knee osteoarthritis made pregnancy and breastfeeding grounds for exclusion^[2], and a current German trial requires consistent contraception during therapy for anyone who could become pregnant^[3].

The reasoning is simple. The treatment is aimed at one joint, but a small amount of radiation scatters beyond the treated area. A fetus is most sensitive early in pregnancy, sometimes before a person knows they are pregnant. And there is no benefit here that cannot wait. Osteoarthritis pain is miserable, but it is not urgent, and it has other treatments.

What usually happens instead: treatment is deferred until after the baby is born, and the pain is managed in the meantime with the standard measures, such as exercise therapy, weight management, and pain medication chosen with pregnancy in mind. If you are trying to conceive, say so at the consultation and ask the team directly how they handle timing. Programs differ, and the team treating you can answer this.

Ask: "I am pregnant, I could be pregnant, or we are planning a pregnancy. Should we wait, and what should we use for the pain in the meantime?"

Past Radiation to the Same Joint: The Dose Decides

This one splits into two very different situations, and mixing them up causes needless worry.

The first is past LDRT itself. A second series is a normal part of this treatment. In a 2025 United States series of 69 patients and 168 joints, each phase was 3 Gy in six sessions of 0.5 Gy, and 33 percent of joints received a second phase, with further pain reduction^[4]. German guidance judges the first series first: if pain persists or relief is not enough six to twelve weeks after the first series, a second series may be recommended^[5]. Even so, it is a decision, not a formality. The ArthroRad trial excluded anyone who had already had radiation therapy to the affected joint^[2].

The second situation is past cancer radiation to the same area. That dose was far higher, and it changes the math. The National Cancer Institute puts it this way: if an area of the body has previously been treated with radiation therapy, a patient may not be able to have radiation therapy to that area a second time, depending on how much radiation was given during the initial treatment^[6].

So the record matters more than your memory of it. The team needs the treatment summary from the hospital that treated you: the total dose, the dates, and the exact site. "I had radiation once, years ago" is a starting point, not an answer. Getting that record is the most useful thing you can do before the consultation.

Ask: "I had radiation near this joint in the past. Do you have my record, and what was the total dose to this area?"

Young Age: Why Programs Set a Floor

German guidance, which is where this treatment has the longest track record, frames it at 40. Radiotherapy for painful degenerative joint disorders is recommended only after standard non-radiation treatments have failed, and younger patients, meaning under 40, should be treated only in exceptional cases, after a careful weighing of the risks against the expected benefit^[5][7].

There is no single worldwide rule, though. Each program and each trial sets its own floor. ArthroRad required patients to be over 40^[2]. The Korean LoRD-KNeA trial required age 50 or older^[8]. A patient of 42 may be treated at one center and turned down at another, and both can be following their own rules correctly.

Why the caution? Time. A radiation-caused cancer, if one ever developed, would take years to decades to appear, and the risk of a second malignancy is known to vary with the age at which a person is treated^[1]. A younger patient carries that small risk for more years. A younger patient also has more years ahead in which a joint replacement or another treatment may turn out to be the better path. Our page on whether LDRT can cause cancer works through the risk itself.

What usually happens instead: younger patients are steered first to exercise, weight management, medication, injections, and a surgical opinion, and LDRT is revisited later if those run out.

Ask: "At my age, do you offer LDRT? If not, what would you do first, and when would you reconsider it?"

Connective Tissue Disease: Decided Case by Case

The conditions the team will ask about are scleroderma, which doctors also call systemic sclerosis, lupus, dermatomyositis, and mixed connective tissue disease. These conditions already affect small blood vessels, skin, and connective tissue. The late effects of radiation are also about tissue stiffening and blood vessel change, so the two can add up in the same tissue. That is why the question comes up.

The longest follow-up data come from cancer treatment, and the doses there were far higher than LDRT. In a study of 209 patients with collagen vascular disease treated between 1960 and 1995, severe late effects were more common in the non-rheumatoid conditions than in rheumatoid arthritis, and the authors concluded that rheumatoid arthritis does not appear to carry an elevated rate of late toxicity, while other collagen vascular diseases do, so the choice should be made case by case. The doses in that study ran from 10 to 87.6 Gy, with a median of 45 Gy^[9]. A course for osteoarthritis is 3 to 6 Gy. Read those numbers as the reason doctors ask, not as the risk you face from LDRT. A 2024 review of radiotherapy in systemic sclerosis reached a similar practical conclusion: most patients did not show worsened skin thickening or lung problems after treatment, but the risk varied, so caution is warranted^[10].

One more thing to disclose, even though LDRT involves no incision and leaves no wound to heal: an open sore or broken skin over the joint, poor circulation, diabetes, or surgery planned on that joint. None of these is a proven LDRT problem. All of them are facts the team would rather hear from you than discover on the day.

Ask: "I have scleroderma, or lupus, or another connective tissue condition. Does that change the dose, the joint you would treat, or the decision itself?"

When the Pain Is Not Osteoarthritis

For arthritis, LDRT is aimed at osteoarthritis inside a joint. It does not treat an infection, a fracture, or a tumor, and it does not treat pain that is traveling into the limb from the spine. Using it on the wrong problem wastes the weeks that the real problem needs.

The urgent version of this is a joint infection, called septic arthritis. It almost always shows up over a period of up to two weeks as one or more hot, painful, swollen, and stiff joints, and in that situation infection should be assumed until it is proved otherwise. The absence of a fever or a raised white cell count does not reliably rule it out^[11]. The usual path is urgent care the same day, a sample of fluid drawn from the joint, antibiotics, and an orthopedic consultation^[12]. A joint that turns hot, red, and swollen over a few days is not an LDRT booking. It is an emergency visit.

The slower version is caught by imaging. Before radiotherapy for a painful degenerative disorder, German guidance requires standard X-rays in at least two planes, partly to exclude a tumor process by accident, with MRI, CT, or a bone scan added when the picture is unclear^[5]. That step is also how a fracture or another cause gets found before any treatment starts.

And sometimes the joint on the X-ray is fine and the pain is coming from elsewhere. Groin and leg pain can start in the lower back. Shoulder pain can start in the neck. Confirming the source comes first, and only then does it make sense to treat a joint.

Ask: "Are we sure this pain is osteoarthritis in this joint? What test would prove it, if we are not sure?"

Cancer Treatment in the Same Area, and Devices

If you are being treated for cancer now, or you were treated for cancer in the same area before, the two teams need one shared plan. The osteoarthritis treatment must not add dose to an area being treated for cancer, it must not delay cancer treatment, and it must not be aimed at pain that has not been confirmed as osteoarthritis. Research studies draw this line in writing: a current German trial excludes patients with tumor diseases and anyone who had earlier radiation therapy for cancer^[3].

That is a trial rule, though, not a verdict on you. A cancer history somewhere else in the body does not, by itself, rule you out, and there is no reason to cross yourself off the list before anyone has looked. Bring it up early and let the teams coordinate.

A pacemaker, a defibrillator, metal hardware, or an existing joint replacement near the treated joint is a planning question of the same kind. The team checks what the device is and where it sits in relation to the treatment field before anything is scheduled. We cover that in detail on our page about LDRT with a pacemaker or implants.

Ask: "I am being treated for cancer, or I have a device or an implant near this joint. Who checks that the plans fit together?"

What to Tell the Team Before They Ask

• Every radiation treatment you have ever had, with the year and the hospital that gave it, so the team can request the record and the total dose.
• Whether you are pregnant, could be pregnant, breastfeeding, or planning a pregnancy. This is the one item that stops treatment for now^[1].
• Your age, and what you have already tried. German guidance expects standard treatments to have been tried first, and patients under 40 are treated only in exceptional cases^[5].
• Any connective tissue disease, plus diabetes, circulation problems, or broken skin over the joint.
• Any joint that has become hot, swollen, and hard to move over a few days. That needs urgent care first, with or without a fever^[11].
• Any cancer treatment, past or present, and any implanted device or joint replacement near the joint being considered.

References:
1. Deloch L, et al. From essential basic understanding to clinical application: biological, physical and pathophysiological principles of (low dose) radiotherapy in benign diseases. Frontiers in Immunology. 2025;16:1588470 (radiotherapy absolutely contraindicated during pregnancy; risk of a second malignancy varies with age at treatment). Frontiers
2. Niewald M, et al. ArthroRad trial: multicentric prospective and randomized single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis depending on the dose, results after 3 months follow-up. Strahlentherapie und Onkologie. 2022;198(4):370-377 (excluded pregnancy and breastfeeding, prior radiation therapy to the affected joint, and prior joint replacement; required age above 40). PubMed
3. ClinicalTrials.gov. Investigation of the Clinical Efficacy of Low Dose Ionizing Radiation in the Treatment of Osteoarthritis. NCT05887284 (excludes tumor diseases, earlier radiation therapy for cancer, and people who could become pregnant who do not use consistent contraception during therapy). ClinicalTrials.gov
4. Koneru BN, et al. Low-dose radiation therapy for osteoarthritis: a retrospective single-institution analysis of 69 patients and 168 joints. International Journal of Radiation Oncology, Biology, Physics. 2025;123(2):352-360 (each phase 3 Gy in 6 fractions of 0.5 Gy over 2 to 3 weeks; 33% of joints received a second phase). PubMed
5. Seegenschmiedt MH, Micke O, Muecke R; German Cooperative Group on Radiotherapy for Non-malignant Diseases. Radiotherapy for nonmalignant disorders: state of the art and update of the evidence-based practice guidelines. British Journal of Radiology. 2015;88(1051):20150080 (patients under 40 only in exceptional cases, after standard treatments have failed; a second series may be recommended 6 to 12 weeks after the first; X-rays in two planes required before treatment). PubMed
6. National Cancer Institute. Radiation Therapy for Cancer. Patient fact sheet (an area treated with radiation before may not be treatable a second time, depending on how much radiation was given the first time). cancer.gov
7. Ott OJ, Niewald M, Weitmann HD, et al. DEGRO guidelines for the radiotherapy of non-malignant disorders. Part II: Painful degenerative skeletal disorders. Strahlentherapie und Onkologie. 2015;191(1):1-6 (the German guideline this page's framework follows). PubMed
8. Kim BH, Ro DH, Wang JH, et al. Single course low-dose radiation therapy in knee osteoarthritis (LoRD-KNeA): a randomized controlled trial. BMC Medicine. 2026 (114 patients; required age 50 or older and primary knee osteoarthritis). BMC Medicine
9. Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. Journal of Clinical Oncology. 1997;15(7):2728-2735 (209 patients treated 1960 to 1995; doses 10 to 87.6 Gy, median 45 Gy; rheumatoid arthritis showed no elevated rate of late toxicity, other collagen vascular diseases did; decisions case by case). PubMed
10. Aboabat A, et al. Effects of radiotherapy for malignancy in systemic sclerosis: a systematic review. Journal of Rheumatology. 2024;51(8):744-751 (most patients showed no worsened skin thickening or pulmonary complications; risk was variable, so caution is warranted). Journal of Rheumatology
11. Mathews CJ, Kingsley G, Field M, et al. Management of septic arthritis: a systematic review. Annals of the Rheumatic Diseases. 2007;66(4):440-445 (presents over up to 2 weeks as hot, painful, swollen, restricted joints; sepsis assumed until proved otherwise; absent fever does not exclude it). PMC
12. Long B, Koyfman A, Gottlieb M. Evaluation and management of septic arthritis and its mimics in the emergency department. Western Journal of Emergency Medicine. 2019;20(2):231-244 (joint fluid aspiration is the standard test; treatment includes intravenous antibiotics and an orthopedic surgery consultation). PubMed